Compounds > molybdenum
Page last updated: 2024-08-22

molybdenum and Disease Models, Animal

molybdenum has been researched along with Disease Models, Animal in 64 studies

Research

Studies (64)

TimeframeStudies, this research(%)All Research%
pre-19905 (7.81)18.7374
1990's7 (10.94)18.2507
2000's26 (40.63)29.6817
2010's17 (26.56)24.3611
2020's9 (14.06)2.80

Authors

AuthorsStudies
Alaniz, L; Andujar, S; Casais, M; Conforti, RA; Delsouc, MB; Pacheco, P; Vallcaneras, SS; Vitale, DL1
An, J; Ge, S; Liang, Y; Liu, J; Liu, W; Peng, M; Shi, J; Tan, S; Wang, Y; Wen, Z; Wu, S; Xie, L; Yang, J; Yang, X; Zhang, G; Zhang, K; Zhang, Z; Zhou, T1
Fu, Z; Hu, W; Ji, X; Ni, D; Shi, Y; Wang, H; Wang, Z; Yang, X; Ye, Y; Zhang, C; Zhong, J1
Chen, Y; Jiang, H; Jiang, Z; Li, D; Li, M; Lin, Y; Su, Y; Xiao, Y; Yan, Z; Yang, F; Yang, M1
Brett, DJL; He, G; Lai, F; Li, B; Lu, X; Parkin, IP; Qin, J; Wang, X; Wu, X; Ye, K1
Ambi, A; Hatfield, J; Miller, LM; Sullivan, JK; Van Nostrand, WE; Victor, TW; Xu, F; Zhu, X1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Ai, S; Blažek, P; Brittenham, GM; Chen, D; Chen, YP; Cortez, LM; Daude, N; Deisenhofer, I; Dwivedi, G; Eskandari-Sedighi, G; Fegan, PG; Friedrich, L; Fu, B; Gotoh, M; Grebmer, C; Green, G; Habibi, A; Hadadi, M; Hattori, R; Hectors, SJ; Hegde, AR; Iwata, H; Jabłońska, J; Jafari, R; Kantenwein, V; Karami, S; Kato, M; Kawanishi, H; Kluska, M; Koehne de González, AK; Kolb, C; Kulkarni, VI; Lan, NSR; Lan, X; Lennerz, C; Li, C; Li, Q; Li, X; Li, Y; Lim, MA; Lin, CH; Lin, XJ; Liu, R; Manne, ASN; Murase, Y; Mutalik, S; O'Connor, M; Pranata, R; Prince, MR; Rankin, JM; Rao, RR; Raut, SY; Reents, T; Sassa, N; Schaarschmidt, C; Seko, S; Shi, W; Shmeit, K; Sim, V; Spincemaille, P; Sun, G; Sun, J; Tsuzuki, T; Varmira, K; von Olshausen, G; Walker, MJ; Wang, Y; Wang, Z; Waterhouse, GIN; Weigand, S; Westaway, D; Xu, XM; Yang, J; Yeap, BB; Yi, X; Zhang, J; Zhang, M; Zhang, Y; Zheng, J; Zhou, M1
Feng, W; Li, F; Li, L; Liu, Y; Ma, L; Wei, Z; Zhou, J; Zhu, X1
Fan, Y; Hu, W; Li, D; Li, Y; Shen, M; Shi, X; Wang, X; Xiao, T; Xing, L1
Bai, M; Bao, N; Deng, Z; Gan, J; Qian, H; Wang, Z; Xue, K; Zhao, J; Zhou, G1
Anisimov, VN; Baldueva, IA; Bykov, VN; Drachev, IS; Fedoros, EI; Gubareva, EA; Kraev, SY; Maydin, MA; Panchenko, AV; Pigarev, SE1
Chen, S; Deng, Z; Guo, T; Jiang, H; Jin, J; Meng, J; Qiu, Y; Wang, J; Wang, Y; Zhao, J1
Hsu, PY; Su, CC; Yang, TH; Yen, HH1
Cui, Z; Li, Z; Liang, Y; Liu, X; Ma, M; Tan, L; Wu, S; Yang, X; Yeung, KWK; Zheng, Y1
Garattini, E; Terao, M1
Chen, C; Lü, JM; Yao, Q1
Ale-Ebrahim, M; Eidi, A; Mortazavi, P; Tavangar, SM; Tehrani, DM1
Chen, DB; Feng, L; Hou, HM; Li, XH; Liu, JX; Wei, LT; Wu, C; Zhang, JW1
Bao, T; Dong, X; Gu, Z; Ma, X; Tian, G; Wang, Z; Yin, W; Yu, J; Zhang, X; Zhao, Y; Zheng, X1
Chen, L; Chen, M; Li, MH; Li, YD; Wang, W; Wang, YL; Yuan, GY; Zhang, J1
Chen, Y; Li, B; Li, J; Li, Y; Peng, X; Qin, H; Zhao, Y1
Ishige, K; Ito, Y; Okawa, E; Ono, S; Suzuki, T; Tokuda, E; Watanabe, S1
Abrams, GD; Brewer, GJ; Dick, R; Hou, G2
George, GN; Lichtmannegger, J; Pickering, IJ; Summer, KH; Webb, S; Zhang, L1
Albin, RL; Benton, K; Brewer, GJ; Dick, R; Hou, G; Janiszewska, A; Tallaksen-Greene, SJ1
Hanahan, D; Ishida, S; McCormick, F; Smith-McCune, K1
Beckman, JS; Frei, B; Wei, H; Zhang, WJ1
Frei, B; Leboeuf, RC; McMillen, TS; Wei, H; Zhang, WJ1
Marklund, SL; Okawa, E; Ono, S; Tokuda, E; Watanabe, S1
Bias, C; Bottema, KM; Brewer, GJ; De Carvalho, M; Dick, RD; Irani, J; Kleer, CG; Merajver, SD; Mesri, EA; Pan, Q; Robins, DM; van Golen, KL1
Gailer, J; George, GN; Harris, HH; Klein, D; Lichtmannegger, J; Pickering, IJ; Summer, KH1
Brewer, GJ; Dick, R; Olivarez, L; Phan, SH; Ullenbruch, MR1
Brewer, GJ; Cox, C; Dick, RD; Lee, JS; Merajver, SD; Teknos, TN; Yoo, S1
Arora, U; Finckh, M; Heinzmann, U; Klein, D; Lichtmannegger, J; Summer, KH1
Brewer, GJ; Dick, R; Jin, H; Phan, SH; Ullenbruch, MR1
Brewer, GJ; Dick, RD; Elner, SG; Elner, VM; Yoshida, A1
Abarbanell, AM; Arenberg, DA; Carron, M; Carskadon, SL; Islam, M; Marcus, B; Merajver, SD; Nor, JE; Pan, Q; Paul, S; Teknos, TN; Vandenberg, CD1
Ishino, H; Kawahito, Y; Kimura, M; Kohno, M; Omoto, A; Prudovsky, I; Sano, H; Tubouchi, Y; Wada, M; Yoshida, M; Yoshikawa, T; Yoshimura, R1
Brewer, GJ; Dick, R; Hou, G; Zeng, C2
Baklanov, D; de Muinck, ED; Lindner, V; Maciag, T; Mandinov, L; Mandinova, A; Moodie, KL; Redican, F; Simons, M; Zhuang, Z1
Eriguchi, M; Hisa, T; Kasano, H; Mitsui, S; Ogata, A; Yamase, T; Yanagie, H1
Harris, AL; Lowndes, SA1
Hassouneh, B; Islam, M; Merajver, SD; Nagel, T; Pan, Q; Teknos, TN1
Arteel, GE; Barve, S; Brewer, GJ; Chen, T; Liu, M; McClain, CJ; Song, M; Song, Z; Zhang, J1
Yang, CS1
Calabrese, E; DiNardi, S; Moore, G; Sacco, C1
Birkner, J; Chiang, G; Dulak, L; Farruggella, TJ; Gunnison, AF; Zaccardi, J1
Ogra, Y; Ohmichi, M; Suzuki, KT2
Ogra, Y; Suzuki, KT1
Ikeda, T; Lai, YR; Sugawara, C; Sugawara, N1
Lai, YR; Sugawara, C; Sugawara, N1
Chiasson, JL; Srivastava, AK1
Chikusa, H; Ogra, Y; Suzuki, KT1
Agostini M, C; Auza, N; Igarza, L; Quiroga, MA1
Anke, M; Danielsson, R; Frank, A1
Danielsson, R; Frank, A; Jones, B1
Ogura, Y; Suzuki, KT1
Cherian, MG; Czachor, JD; Koropatnick, J1
Gooneratne, SR1
Danks, DM1

Reviews

7 review(s) available for molybdenum and Disease Models, Animal

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Aldehyde oxidase and its importance in novel drug discovery: present and future challenges.
    Expert opinion on drug discovery, 2013, Volume: 8, Issue:6

    Topics: Aldehyde Oxidase; Animals; Computer Simulation; Disease Models, Animal; Drug Discovery; Flavoproteins; Humans; Molybdenum; Substrate Specificity

2013
The role of copper in tumour angiogenesis.
    Journal of mammary gland biology and neoplasia, 2005, Volume: 10, Issue:4

    Topics: Animals; Biological Transport; Copper; Disease Models, Animal; Endothelial Cells; Humans; Models, Biological; Models, Chemical; Molybdenum; Neoplasms; Neovascularization, Pathologic; Prognosis; Up-Regulation

2005
Research on esophageal cancer in China: a review.
    Cancer research, 1980, Volume: 40, Issue:8 Pt 1

    Topics: Animals; China; Diet; Disease Models, Animal; Esophageal Neoplasms; Food Contamination; Humans; Molybdenum; Mycoses; Nitrosamines; Trace Elements; Zinc

1980
[Insulin-like effects of vanadium and other metallic ions. Potential use in the treatment of diabetes].
    Journees annuelles de diabetologie de l'Hotel-Dieu, 1999

    Topics: Animals; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Molybdenum; Selenium; Tungsten; Vanadium

1999
[Biological regulation of copper and selective removal of copper: therapy for Wilson disease and its molecular mechanism].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2000, Volume: 120, Issue:10

    Topics: Adenosine Triphosphatases; Animals; Carrier Proteins; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transporting ATPases; Disease Models, Animal; Hepatolenticular Degeneration; Humans; Liver; Metallothionein; Molybdenum; Rats; Rats, Inbred LEC; Recombinant Fusion Proteins

2000
Inborn errors of trace element metabolism.
    Clinics in endocrinology and metabolism, 1985, Volume: 14, Issue:3

    Topics: Acrodermatitis; Animals; Breast Feeding; Copper; Cutis Laxa; Disease Models, Animal; Female; Hepatolenticular Degeneration; Humans; Infant, Newborn; Infant, Premature, Diseases; Liver; Manganese; Menkes Kinky Hair Syndrome; Metabolism, Inborn Errors; Molybdenum; Pregnancy; Prenatal Diagnosis; Trace Elements; Zinc

1985

Trials

1 trial(s) available for molybdenum and Disease Models, Animal

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021

Other Studies

57 other study(ies) available for molybdenum and Disease Models, Animal

ArticleYear
Antiproliferative and antiangiogenic effects of ammonium tetrathiomolybdate in a model of endometriosis.
    Life sciences, 2021, Dec-15, Volume: 287

    Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; Disease Models, Animal; Endometriosis; Female; Mice; Mice, Inbred C57BL; Molybdenum

2021
Bionic Regulators Break the Ecological Niche of Pathogenic Bacteria for Modulating Dysregulated Microbiome in Colitis.
    Advanced materials (Deerfield Beach, Fla.), 2022, Volume: 34, Issue:39

    Topics: Animals; Bionics; Calcium; Colitis; Dextran Sulfate; Disease Models, Animal; Escherichia coli; Gastrointestinal Microbiome; Leukocyte L1 Antigen Complex; Mannose; Mice; Mice, Inbred C57BL; Molybdenum; Prebiotics; Tungsten

2022
Oral zero-valent-molybdenum nanodots for inflammatory bowel disease therapy.
    Science advances, 2022, 09-16, Volume: 8, Issue:37

    Topics: Animals; Colitis; Disease Models, Animal; Inflammatory Bowel Diseases; Metal Nanoparticles; Mice; Molybdenum; NF-kappa B; Reactive Oxygen Species

2022
pH-sensitive molybdenum (Mo)-based polyoxometalate nanoclusters have therapeutic efficacy in inflammatory bowel disease by counteracting ferroptosis.
    Pharmacological research, 2023, Volume: 188

    Topics: Animals; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Ferroptosis; Hydrogen-Ion Concentration; Mice; Molybdenum; Reactive Oxygen Species

2023
Differential Phagocytosis-Based Photothermal Ablation of Inflammatory Macrophages in Atherosclerotic Disease.
    ACS applied materials & interfaces, 2019, Nov-06, Volume: 11, Issue:44

    Topics: Animals; Apoptosis; Atherosclerosis; Bone Marrow Cells; Carotid Arteries; Cell Survival; Disease Models, Animal; Endothelial Cells; Humans; Infrared Rays; Macrophages; Male; Metal Nanoparticles; Mice; Mice, Knockout; Molybdenum; Oxides; Phagocytosis; Phototherapy; Semiconductors; Tissue Distribution

2019
Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques.
    Metallomics : integrated biometal science, 2020, 04-01, Volume: 12, Issue:4

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cerebral Amyloid Angiopathy; Chelating Agents; Copper; Disease Models, Animal; Humans; Mice, Transgenic; Microscopy, Fluorescence; Molybdenum; Parenchymal Tissue; Plaque, Amyloid

2020
    Journal of clinical orthopaedics and trauma, 2021, Volume: 12, Issue:1

    Topics: Acute Coronary Syndrome; Adolescent; Adsorption; Adult; Aged; Animals; Aspergillus; Aspergillus oryzae; Benzhydryl Compounds; Biocatalysis; Biological Availability; Biomarkers; Biomass; Brain; Brain Injuries, Traumatic; Cadmium; Calorimetry, Differential Scanning; Carbon; Carcinoma, Transitional Cell; Catalysis; Cell Death; Cells, Immobilized; Child; Child, Preschool; China; Chitosan; Creatine Kinase, MB Form; Cyclodextrins; Defibrillators, Implantable; Dendritic Spines; Diabetes Mellitus, Type 2; Diastole; Directed Molecular Evolution; Disease Models, Animal; Disease Progression; Down-Regulation; Electric Countershock; Electrolytes; Electrophoresis, Polyacrylamide Gel; Endopeptidase K; Environmental Monitoring; Esterification; Esters; Feasibility Studies; Female; Fruit; Gene Library; Glial Fibrillary Acidic Protein; Glucosides; Hippocampus; Humans; Hydrogen-Ion Concentration; Hydrolysis; Infant; Infant, Newborn; Inflammation; Ions; Kinetics; Lipase; Liver Cirrhosis; Logistic Models; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malus; Maze Learning; Melatonin; Mercury; Mice; Mice, Inbred C57BL; Middle Aged; Mining; Molecular Docking Simulation; Molecular Weight; Molybdenum; Motor Cortex; Mutagenesis, Site-Directed; Mutation; Neoplasm Recurrence, Local; Nephrectomy; Nephroureterectomy; Neurons; Oxidative Stress; Patient Discharge; Proof of Concept Study; Propionates; Prospective Studies; Protein Engineering; Protein Structure, Quaternary; Protons; PrPC Proteins; PrPSc Proteins; Rats; Rats, Wistar; Recovery of Function; Registries; Retrospective Studies; Rivers; ROC Curve; Scrapie; Sodium-Glucose Transporter 2 Inhibitors; Solubility; Solvents; Spatial Memory; Stereoisomerism; Synapses; Temperature; Time Factors; Treatment Outcome; Troponin T; Urinary Bladder Neoplasms; Urinary Tract; Ventricular Function, Left; Ventricular Remodeling; Water; Water Pollutants, Chemical; Water Purification; X-Ray Diffraction; Young Adult; Zebrafish

2021
Customized Photothermal Therapy of Subcutaneous Orthotopic Cancer by Multichannel Luminescent Nanocomposites.
    Advanced materials (Deerfield Beach, Fla.), 2021, Volume: 33, Issue:30

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Glutathione; Humans; Infrared Rays; Lanthanoid Series Elements; Luminescent Agents; Metal Nanoparticles; Mice; Molybdenum; Nanocomposites; Neoplasms; Photothermal Therapy; Silicon Compounds; Surface Properties; Theranostic Nanomedicine

2021
Intelligent Molybdenum Disulfide Complexes as a Platform for Cooperative Imaging-Guided Tri-Mode Chemo-Photothermo-Immunotherapy.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021, Volume: 8, Issue:14

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Disulfides; Immunotherapy; Mice; Molybdenum; Nanoparticle Drug Delivery System; Neoplasms; Photoacoustic Techniques; Phototherapy; Radiography, Interventional; Tomography, X-Ray Computed

2021
Probiotics protect mice from CoCrMo particles-induced osteolysis.
    International journal of nanomedicine, 2017, Volume: 12

    Topics: Animals; Bone Resorption; Chromium; Cobalt; Disease Models, Animal; Gene Expression Regulation; Interleukin-10; Interleukin-4; Lacticaseibacillus casei; Macrophages; Mice; Molybdenum; Nitric Oxide Synthase Type II; Osteoclasts; Osteolysis; Probiotics; Tumor Necrosis Factor-alpha

2017
Radioprotective and radiomitigative effects of BP-C2, a novel lignin-derived polyphenolic composition with ammonium molybdate, in two mouse strains exposed to total body irradiation.
    International journal of radiation biology, 2018, Volume: 94, Issue:2

    Topics: Acute Radiation Syndrome; Animals; Cell Proliferation; Cell Survival; Disease Models, Animal; Leukocytes, Mononuclear; Lignin; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Molybdenum; Polyphenols; Radiation-Protective Agents; Stem Cells; Whole-Body Irradiation

2018
Construction and Evaluation of a Murine Calvarial Osteolysis Model by Exposure to CoCrMo Particles in Aseptic Loosening.
    Journal of visualized experiments : JoVE, 2018, 02-17, Issue:132

    Topics: Animals; Chromium; Cobalt; Disease Models, Animal; Macrophages; Mice; Mice, Inbred C57BL; Molybdenum; Osteolysis; X-Ray Microtomography

2018
Tetrathiomolybdate, a copper chelator inhibited imiquimod-induced skin inflammation in mice.
    Journal of dermatological science, 2018, Volume: 92, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Chelating Agents; Copper; Cytokines; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Imiquimod; Inflammation Mediators; Keratinocytes; Male; Mice, Inbred C57BL; Molybdenum; Phosphorylation; Psoriasis; Signal Transduction; Skin; Spleen; STAT3 Transcription Factor

2018
Enhancing the antibacterial efficacy of low-dose gentamicin with 5 minute assistance of photothermy at 50 °C.
    Biomaterials science, 2019, Mar-26, Volume: 7, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Cell Proliferation; Cell Survival; Disease Models, Animal; Disulfides; Escherichia coli; Gentamicins; Male; Mice; Microbial Sensitivity Tests; Molybdenum; NIH 3T3 Cells; Particle Size; Phototherapy; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Surface Properties; Temperature; Titanium

2019
3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
    Biochemical pharmacology, 2013, Nov-01, Volume: 86, Issue:9

    Topics: Administration, Oral; Allopurinol; Animals; Antioxidants; Benzaldehydes; Catechols; Cell-Free System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Gout Suppressants; Hyperuricemia; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Molybdenum; Reactive Oxygen Species; Structure-Activity Relationship; Uric Acid; Xanthine Oxidase

2013
Hepatoprotective and antifibrotic effects of sodium molybdate in a rat model of bile duct ligation.
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2015, Volume: 29

    Topics: Animals; Antioxidants; Bile Ducts; Body Weight; Disease Models, Animal; Ligation; Liver; Liver Cirrhosis; Male; Molybdenum; Organ Size; Protective Agents; Rats; Rats, Wistar

2015
Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: a microdialysis study in vivo.
    Biochemical and biophysical research communications, 2015, Feb-27, Volume: 458, Issue:1

    Topics: Animals; Brain; Chelating Agents; Copper; Corpus Striatum; Disease Models, Animal; Hepatolenticular Degeneration; Hydroxyl Radical; Mice, Inbred C57BL; Mice, Mutant Strains; Microdialysis; Molybdenum; Penicillamine

2015
Smart MoS2/Fe3O4 Nanotheranostic for Magnetically Targeted Photothermal Therapy Guided by Magnetic Resonance/Photoacoustic Imaging.
    Theranostics, 2015, Volume: 5, Issue:9

    Topics: Animals; Disease Models, Animal; Disulfides; Drug Delivery Systems; Ferric Compounds; HeLa Cells; Hep G2 Cells; Humans; Hyperthermia, Induced; Infrared Rays; Magnetic Resonance Imaging; Male; Mice, Inbred BALB C; Molybdenum; Nanoparticles; Neoplasms; Photoacoustic Techniques; Theranostic Nanomedicine; Treatment Outcome

2015
Magnesium alloy covered stent for treatment of a lateral aneurysm model in rabbit common carotid artery: An in vivo study.
    Scientific reports, 2016, 11-21, Volume: 6

    Topics: Alloys; Aneurysm; Animals; Carotid Artery, Common; Disease Models, Animal; Female; Follow-Up Studies; Implants, Experimental; Magnesium; Magnetic Resonance Angiography; Male; Molybdenum; Rabbits; Stents; Ultrasonography, Interventional

2016
Anthocyanin suppresses CoCrMo particle-induced osteolysis by inhibiting IKKα/β mediated NF-κB signaling in a mouse calvarial model.
    Molecular immunology, 2017, Volume: 85

    Topics: Animals; Anthocyanins; Chromium; Cobalt; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; I-kappa B Kinase; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Molybdenum; NF-kappa B; Osteolysis; Random Allocation; Real-Time Polymerase Chain Reaction; Signal Transduction; Skull; X-Ray Microtomography

2017
Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis.
    Experimental neurology, 2008, Volume: 213, Issue:1

    Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Animals; Chelating Agents; Copper; Cysteine; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Female; Humans; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molybdenum; Spinal Cord; Superoxide Dismutase; Survival Rate; Treatment Outcome

2008
Efficacy of tetrathiomolybdate in a mouse model of multiple sclerosis.
    Translational research : the journal of laboratory and clinical medicine, 2008, Volume: 152, Issue:5

    Topics: Animals; Chelating Agents; Copper; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred Strains; Molybdenum; Motor Activity; Multiple Sclerosis; Oxidative Stress

2008
Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease.
    Biochemistry, 2009, Feb-10, Volume: 48, Issue:5

    Topics: Adenosine Triphosphatases; Animals; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transporting ATPases; Disease Models, Animal; Hepatolenticular Degeneration; Kidney; Liver; Molybdenum; Prospective Studies; Rats; Rats, Inbred LEC; Rats, Mutant Strains

2009
Evaluation of tetrathiomolybdate in the R6/2 model of Huntington disease.
    Neuroscience letters, 2009, Mar-06, Volume: 452, Issue:1

    Topics: Age Factors; Animals; Brain; Disease Models, Animal; Huntington Disease; Intranuclear Inclusion Bodies; Mice; Mice, Transgenic; Molybdenum; Motor Activity; Reaction Time; Survival Rate

2009
Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator.
    Cancer cell, 2010, Jun-15, Volume: 17, Issue:6

    Topics: Adenosine Triphosphatases; Adjuvants, Pharmaceutic; Adult; Aged; Aged, 80 and over; Animal Structures; Animals; Carboplatin; Cation Transport Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chelating Agents; Cisplatin; Copper; Copper Transporter 1; Copper-Transporting ATPases; Disease Models, Animal; Disease-Free Survival; DNA Adducts; Female; Gene Expression; Humans; Mice; Mice, Inbred Strains; Middle Aged; Molybdenum; Neoplasms; Neovascularization, Pathologic; Ovarian Neoplasms; Treatment Outcome; Uterine Cervical Neoplasms

2010
Copper chelation by tetrathiomolybdate inhibits lipopolysaccharide-induced inflammatory responses in vivo.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:3

    Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Ceruloplasmin; Chelating Agents; Chemokine CCL2; Copper; Disease Models, Animal; Female; Gene Expression Regulation; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Molybdenum; NF-kappa B; Oxidation-Reduction; RNA, Messenger; Superoxide Dismutase; Transcription Factor AP-1; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1

2011
Copper chelation by tetrathiomolybdate inhibits vascular inflammation and atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Atherosclerosis, 2012, Volume: 223, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biomarkers; Cell Adhesion Molecules; Ceruloplasmin; Chelating Agents; Copper; Cytokines; Disease Models, Animal; Female; Inflammation; Inflammation Mediators; Iron; Lipids; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Molybdenum; Myocardium

2012
Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities.
    Neurobiology of disease, 2013, Volume: 54

    Topics: Amyotrophic Lateral Sclerosis; Animals; Chelating Agents; Copper; Disease Models, Animal; Homeostasis; Humans; Mice; Mice, Transgenic; Molybdenum; Motor Neurons; Mutation; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1

2013
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.
    Cancer research, 2002, Sep-01, Volume: 62, Issue:17

    Topics: Angiogenesis Inhibitors; Animals; Breast Neoplasms; Cell Division; Copper; Disease Models, Animal; Female; Genes, erbB-2; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mice, Transgenic; Molybdenum; Neovascularization, Pathologic; NF-kappa B; Rats; Rats, Sprague-Dawley; Transcription, Genetic; Xenograft Model Antitumor Assays

2002
Tetrathiomolybdate causes formation of hepatic copper-molybdenum clusters in an animal model of Wilson's disease.
    Journal of the American Chemical Society, 2003, Feb-19, Volume: 125, Issue:7

    Topics: Animals; Copper; Disease Models, Animal; Fourier Analysis; Hepatolenticular Degeneration; Humans; Liver; Lysosomes; Molecular Structure; Molybdenum; Rats; Rats, Inbred LEC; Spectrometry, X-Ray Emission; Sulfur

2003
Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice.
    The Journal of laboratory and clinical medicine, 2003, Volume: 141, Issue:3

    Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Bleomycin; Body Weight; Ceruloplasmin; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hydroxyproline; Lung; Mice; Mice, Inbred CBA; Molybdenum; Pulmonary Fibrosis

2003
Inhibition of the growth of squamous cell carcinoma by tetrathiomolybdate-induced copper suppression in a murine model.
    Archives of otolaryngology--head & neck surgery, 2003, Volume: 129, Issue:7

    Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Mice; Mice, Inbred C3H; Molybdenum; Random Allocation

2003
Tetrathiomolybdate in the treatment of acute hepatitis in an animal model for Wilson disease.
    Journal of hepatology, 2004, Volume: 40, Issue:3

    Topics: Acute Disease; Animals; Chelating Agents; Copper; Disease Models, Animal; Female; Hepatitis, Animal; Hepatolenticular Degeneration; Liver; Microscopy, Electron; Molybdenum; Rats; Rats, Inbred LEC; Rats, Long-Evans; Subcellular Fractions; Tissue Distribution

2004
Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis.
    Journal of inorganic biochemistry, 2004, Volume: 98, Issue:12

    Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Bleomycin; Ceruloplasmin; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Lung; Mice; Mice, Inbred CBA; Molybdenum; Pulmonary Fibrosis; Time Factors

2004
Effects of tetrathiomolybdate in a mouse model of retinal neovascularization.
    Investigative ophthalmology & visual science, 2005, Volume: 46, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Chelating Agents; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Fluorescein Angiography; Injections, Intraperitoneal; Ischemia; Mice; Mice, Inbred C57BL; Molybdenum; Retinal Neovascularization; Vascular Endothelial Growth Factor A

2005
The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck.
    Archives of otolaryngology--head & neck surgery, 2005, Volume: 131, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Biomarkers, Tumor; Biopsy, Needle; Carcinoma, Squamous Cell; Cell Movement; Cytokines; Disease Models, Animal; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Vitro Techniques; Mice; Mice, SCID; Molybdenum; Neovascularization, Pathologic; Probability; Rats; Rats, Sprague-Dawley; Risk Assessment; Sensitivity and Specificity; Species Specificity; Tumor Burden; Tumor Cells, Cultured

2005
Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice.
    The Journal of laboratory and clinical medicine, 2005, Volume: 146, Issue:5

    Topics: Adenosine Triphosphatases; Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Chelating Agents; Creatine Kinase; Disease Models, Animal; Doxorubicin; Drug Therapy, Combination; Interleukin-1; Interleukin-2; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Molybdenum; Troponin I; Tumor Necrosis Factor-alpha

2005
Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats.
    Arthritis research & therapy, 2005, Volume: 7, Issue:6

    Topics: Administration, Oral; Animals; Arthritis, Experimental; Biomarkers; Cachexia; Chelating Agents; Chelation Therapy; Copper; Disease Models, Animal; Female; Hindlimb; Immunoenzyme Techniques; Joints; Molybdenum; Rats; Rats, Inbred Lew; Synovial Membrane; Vascular Endothelial Growth Factor A

2005
The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model.
    Journal of inorganic biochemistry, 2006, Volume: 100, Issue:5-6

    Topics: Animals; Autoimmune Diseases; Diabetes Mellitus, Type 1; Disease Models, Animal; Fibrosis; Inflammation; Mice; Mice, Inbred NOD; Molybdenum; Obesity

2006
Inhibition of in-stent restenosis by oral copper chelation in porcine coronary arteries.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:6

    Topics: Animals; Ceruloplasmin; Chelating Agents; Chelation Therapy; Copper; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Male; Molybdenum; Stents; Swine; Time Factors; Tunica Intima; Ultrasonography, Interventional

2006
Antitumor activity of polyoxomolybdate, [NH3Pri]6[Mo7O24].3H2O, against, human gastric cancer model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2006, Volume: 60, Issue:7

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Mice; Mice, Nude; Molybdenum; Oxides; Specific Pathogen-Free Organisms; Stomach Neoplasms

2006
Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models.
    Translational research : the journal of laboratory and clinical medicine, 2006, Volume: 148, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Ceruloplasmin; Copper; Creatine Kinase; Delayed-Action Preparations; Disease Models, Animal; Doxorubicin; Drug Antagonism; Heart; Instillation, Drug; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Molybdenum; Neoplasm Transplantation; Neoplasms; Troponin I; Zinc

2006
Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:3

    Topics: Adenosine Triphosphatases; Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Cell Movement; Ceruloplasmin; Disease Models, Animal; Head and Neck Neoplasms; Humans; Lung Neoplasms; Mice; Mice, Nude; Molybdenum; Necrosis; Neovascularization, Pathologic; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2007
Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 325, Issue:2

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bile Ducts; Bilirubin; Ceruloplasmin; Cholestasis; Copper; Disease Models, Animal; Fibrosis; gamma-Glutamyltransferase; Gene Expression; Ligation; Liver; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Molybdenum; Protective Agents; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2008
Sulfite oxidase deficiency: a high risk factor in SO2, sulfite, and bisulfite toxicity?
    Medical hypotheses, 1981, Volume: 7, Issue:2

    Topics: Animals; Cricetinae; Cricetulus; Disease Models, Animal; Environmental Pollutants; Humans; Lung Diseases; Models, Biological; Molybdenum; Mutagens; Oxidoreductases; Oxidoreductases Acting on Sulfur Group Donors; Rats; Risk; Sulfites; Sulfur Dioxide

1981
A sulphite-oxidase-deficient rat model: metabolic characterization.
    Food and cosmetics toxicology, 1981, Volume: 19, Issue:2

    Topics: Animals; Diet; Disease Models, Animal; Female; Liver; Molybdenum; Oxidoreductases; Oxidoreductases Acting on Sulfur Group Donors; Rats; Rats, Inbred Strains; Sulfites; Sulfonic Acids; Thiosulfonic Acids; Tungsten

1981
Systemic dispositions of molybdenum and copper after tetrathiomolybdate injection in LEC rats.
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 1995, Volume: 9, Issue:3

    Topics: Animals; Brain; Chelating Agents; Copper; Disease Models, Animal; Feces; Gastric Mucosa; Half-Life; Hepatolenticular Degeneration; Injections, Intraperitoneal; Intestinal Mucosa; Intestines; Kidney; Liver; Lung; Male; Mass Spectrometry; Molybdenum; Rats; Rats, Mutant Strains; Rats, Wistar; Spleen; Stomach; Testis; Tissue Distribution

1995
Molybdenum and copper kinetics after tetrathiomolybdate injection in LEC rats: specific role of serum albumin.
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 1995, Volume: 9, Issue:3

    Topics: Animals; Chelating Agents; Chromatography, High Pressure Liquid; Copper; Disease Models, Animal; Dose-Response Relationship, Drug; Half-Life; Hepatolenticular Degeneration; Injections, Intraperitoneal; Liver; Male; Mass Spectrometry; Molybdenum; Protein Binding; Rats; Rats, Mutant Strains; Rats, Wistar; Serum Albumin; Tissue Distribution

1995
Targeting of tetrathiomolybdate on the copper accumulating in the liver of LEC rats.
    Journal of inorganic biochemistry, 1998, Volume: 70, Issue:1

    Topics: Animals; Biological Transport, Active; Ceruloplasmin; Copper; Disease Models, Animal; Female; Hepatolenticular Degeneration; Liver; Metallothionein; Molybdenum; Protein Binding; Rats; Rats, Mutant Strains

1998
The effect of subcutaneous tetrathiomolybdate administration on copper and iron metabolism, including their regional redistribution in the brain, in the Long-Evans Cinnamon rat, a bona fide animal model for Wilson's disease.
    Pharmacology & toxicology, 1999, Volume: 84, Issue:5

    Topics: Animals; Brain; Ceruloplasmin; Copper; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Ferritins; Hepatolenticular Degeneration; Injections, Subcutaneous; Iron; Kidney; Liver; Male; Metallothionein; Molybdenum; Rats; Rats, Inbred LEC

1999
Therapeutic effects of tetrathiomolybdate on hepatic dysfunction occurring naturally in Long-Evans Cinnamon (LEC) rats: a bona fide animal model for Wilson's disease.
    Research communications in molecular pathology and pharmacology, 1999, Volume: 103, Issue:2

    Topics: Animals; Bile; Body Weight; Chelating Agents; Copper; Disease Models, Animal; Hepatolenticular Degeneration; Jaundice; Liver; Male; Molybdenum; Rats; Rats, Inbred F344; Rats, Long-Evans; Tissue Distribution

1999
Metabolic fate of the insoluble copper/tetrathiomolybdate complex formed in the liver of LEC rats with excess tetrathiomolybdate.
    Journal of inorganic biochemistry, 2000, Jan-30, Volume: 78, Issue:2

    Topics: Animals; Copper; Disease Models, Animal; Feces; Half-Life; Hepatolenticular Degeneration; Liver; Molybdenum; Rats; Rats, Long-Evans

2000
[Experimental model for the study of molybdenosis in the primary copper deficiency in rats].
    Acta physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia, 1999, Volume: 49, Issue:3

    Topics: Animals; Ceruloplasmin; Copper; Disease Models, Animal; Female; Hematocrit; Male; Molybdenum; Rats; Rats, Wistar; Weight Gain

1999
Experimental copper and chromium deficiency and additional molybdenum supplementation in goats. I. Feed consumption and weight development.
    The Science of the total environment, 2000, Apr-17, Volume: 249, Issue:1-3

    Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Chromium; Copper; Deficiency Diseases; Dietary Supplements; Disease Models, Animal; Eating; Goats; Male; Molybdenum; Weight Gain

2000
Experimental copper and chromium deficiency and additional molybdenum supplementation in goats. II. Concentrations of trace and minor elements in liver, kidneys and ribs: haematology and clinical chemistry.
    The Science of the total environment, 2000, Apr-17, Volume: 249, Issue:1-3

    Topics: Animals; Blood Chemical Analysis; Chromium; Copper; Deficiency Diseases; Dietary Supplements; Disease Models, Animal; Goats; Kidney; Liver; Male; Molybdenum; Multivariate Analysis; Ribs; Trace Elements

2000
Reduction of copper and metallothionein in toxic milk mice by tetrathiomolybdate, but not deferiprone.
    Journal of inorganic biochemistry, 2002, Jan-15, Volume: 88, Issue:2

    Topics: Animals; Copper; Deferiprone; Disease Models, Animal; Hepatolenticular Degeneration; Metallothionein; Mice; Mice, Mutant Strains; Molybdenum; Phenotype; Pyridones

2002
Potential use of tetrathiomolybdate in copper storage diseases.
    Acta pharmacologica et toxicologica, 1986, Volume: 59 Suppl 7

    Topics: Animals; Bile; Chelating Agents; Copper; Disease Models, Animal; Feces; Liver; Metal Metabolism, Inborn Errors; Molybdenum

1986